cdc-coteauxdegaronne
» » Anti-Tuberculosis Drug Resistance in the World: Report No. 3 Prevalence and Trends (The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance)
eBook Anti-Tuberculosis Drug Resistance in the World: Report No. 3 Prevalence and Trends (The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance) ePub

eBook Anti-Tuberculosis Drug Resistance in the World: Report No. 3 Prevalence and Trends (The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance) ePub

by World Health Organization

  • ISBN: 9241562854
  • Category: Medicine
  • Subcategory: Medicine
  • Author: World Health Organization
  • Language: English
  • Publisher: World Health Organization (December 2004)
  • Pages: 299
  • ePub book: 1432 kb
  • Fb2 book: 1242 kb
  • Other: txt docx mobi rtf
  • Rating: 4.3
  • Votes: 124

Description

in drug resistance surveillance . 1 Statistical analysis of trends . Ecological analysis of drug resistance and national tuberculosis programme characteristics .

in drug resistance surveillance . 1 Variables included in the ecological analysis . 2 Statistical analysis of ecological data . 0 Effect of demographics and other individual patient's data on drug resistance . 0. 1 Participant countries and procedures. 3. RESULTS . Phase 2 of the Global Project (1996–1999) C . 1 Drug resistance among new cases of tuberculosis . 1 Magnitude of the problem in Mainland China .

Anti-tuberculosis drug resistance in the world Report no. 4. This report provides an analysis of drug resistance survey and surveillance data from 93 different al settings, between 2002 and 2007 by WH. . This report provides an analysis of drug resistance survey and surveillance data from 93 different al settings, between 2002 and 2007 by WHO and the International Union Against Tuberculosis and Lung Disease Global Project. Anti-tuberculosis drug resistance in the world Report no. This report provides an analysis of drug resistance survey and surveillance data from 77 different al settings, between 1999 and 2002 by WHO and the International Union Against Tuberculosis and Lung Disease Global Project.

Since the launch of the Global Project on Anti-tuberculosis Drug Resistance Surveillance in 1994, drug resistance data have been systematically collected and analysed from 127 countries.

Since the launch of the Global Project on Anti-tuberculosis Drug Resistance Surveillance in 1994, drug resistance data have been systematically collected and analysed from 127 countries, or 66% of WHO’s 193 Member States. This includes 64 countries that have continuous surveillance systems based on routine diagnostic drug susceptibility testing of all patients.

Anti-Tuberculosis Drug Resistance in the World, Fourth Global Report, World Health Organization, Geneva, 2008. has been cited by the following article: TITLE: Molecular Detection of Resistance to Rifampin and Isoniazid among Patients Eligible for Retreatment Regimen in Côte d’Ivoire in 2012. AUTHORS: Kouassi N’Guessan, Timothée Ouassa, Jean-Serge Assi, André Tehe, Jean-Marc Assande, André Guei, Jacquemin Kouakou. KEYWORDS: Tuberculosis; Molecular Detection; Drug-Resistance. JOURNAL NAME: Advances in Infectious Diseases, Vo. N., June 5, 2013

Anti-tuberculosis Drug Resistance in the world. 19. World Health Organization: Anti-tuberculosis drug resistance in the world: Report Number 4. The WHO/IUALTD global project on anti-tuberculosis drug resistance surveillance // WHO/HTM/TB/2008.

Anti-tuberculosis Drug Resistance in the world. Report № 3. WHO. Geneva, 2004. For citation: Vаsilyevа . MULTI DRUG RESISTANT TUBERCULOSOS IN THE COUNTRIES OF THE OUTER WORLD AND IN THE RUSSIANFEDERATION. Tuberculosis and Lung Diseases.

This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during.

This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during the years 1999 to 2002. Global surveillance identifies areas of high resistance and draws the attention of national authorities to address the problems involved. This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during the years 1999 to 2002.

drug resistance and to monitor trends. project remains the oldest and largest initiative. on the surveillance of antimicrobial resistance in. the world. 9. In this article, we describe the histor y. of global surveillance of drug resistance in tuber-. drug resistance was published by the WHO in. 1997 with results from surveys conducted in 35. countries.

Start by marking Anti-Tuberculosis Drug Resistance in the World: The . The WHO is responsible for the World Health Report, a leading international publication on health, the worldwide World.

Start by marking Anti-Tuberculosis Drug Resistance in the World: The Who/Iuatld Global Project on Anti-Tuberculosis Drug Resistance Surveillance as Want to Read: Want to Read savin. ant to Read. The constitution of the World Health Organization had been signed by 61 countries on 22 July 1946, with the first meeting of the World Health Assembly finishing on 24 July 1948. The WHO is responsible for the World Health Report, a leading international publication on health, the worldwide World Health Survey, and World Health Day (7 April of every year). Books by World Health Organization.

The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a medical center in Taiwan

The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance. Antituberculosis drug resistance in the world. Report no. WHO/HTM/TB/2008. Geneva, Switzerland: World Health Organization, 2008, pp. 1–120. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a medical center in Taiwan. Clinical Infectious Diseases 2008; 47: e57–63. aramasivan, CN, et al.

The WHO/IUATLD 3rd global report on anti-tuberculosis drug resistance in the world provides data from drug resistance surveys conducted in 77 different countries/geographical settings between 1999 and 2002. The aim of the project is to collect standardized, reliable, and comparable worldwide information on drug resistance of Mycobacterium tuberculosis.